Patent Assignment
Reel/Frame 071191/0975
Assignment of Assignor's Interest
Recorded: 2025-05-22
Pages: 14
Assignors
PANICUCCI, RICCARDO
Executed: 2025-04-28
MONTEITH, MICHAEL
Executed: 2025-04-30
LI, GANG
Executed: 2025-04-11
ARANGIO, SUSAN
Executed: 2025-04-18
BERMAN, CRAIG
Executed: 2025-05-19
HOWLAND, MICHAEL
Executed: 2025-04-11
MULREANY, DANIEL
Executed: 2025-04-12
DAMBKOWSKI, CARL
Executed: 2025-04-14
Assignee
QED THERAPEUTICS, INC.
75 FEDERAL STREET, SAN FRANCISCO, CALIFORNIA, 94107
Covered Property
(1)
Methods of Treating Cholangiocarcinoma
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →